Jennifer Doudna
Director/Board Member at
JOHNSON & JOHNSON
Net worth: 1 M $ as of 2026-05-30
Profile
Jennifer A. Doudna founded Editas Medicine, Inc. in 2013, Caribou Biosciences, Inc. in 2010, Intellia Therapeutics, Inc. in 2010, Mammoth Biosciences, Inc. in 2017, and Innovative Genomics Institute in 2014, where she is working as Chairman & President from 2014.
Dr. Doudna also founded Aurora Therapeutics, Inc., Scribe Therapeutics, Inc., and Azalea Therapeutics, Inc. Dr. Doudna also currently works at Johnson & Johnson, as Independent Director from 2018, Driver, Inc., as Director, Altos Labs, Inc., as Director, Tempus AI, Inc., as Independent Director from 2021, Pomona College, as Trustee, the University of California, Berkeley, as Professor from 2002, Lawrence Berkeley National Laboratory, as Member-Molecular, Cell Biology & Chemistry, National Academy of Sciences, as Member-Molecular, Cell Biology & Chemistry, American Academy of Arts & Sciences, as Member-Molecular, Cell Biology & Chemistry, Li Ka Shing (Canada) Foundation, as Chancellor Chair, The Column Group LLC, as iPartner, Sixth Street Advisers LLC (Private Equity), as Chief Science Advisor from 2022, and eFFECTOR Therapeutics, Inc., as Scientific Advisory Board.
Dr. Doudna also formerly worked at Genentech, Inc., as Vice President-Discovery Research, Pfizer Inc., as Consultant, The Royal Society, as Member, Howard Hughes Medical Institute, Inc., as Member-Molecular, Cell Biology & Chemistry, Orchard Venture Partners, as Advisor, and Merck Ltd., as Consultant.
Dr. Doudna received her undergraduate degree from Pomona College and doctorate degree from Harvard Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-20 | 28,615 ( 0.02% ) | 1 M $ | 2026-05-30 | |
JOHNSON & JOHNSON -.--% | 2026-04-22 | 0 ( -.--% ) | - $ | 2026-05-30 |
Jennifer Doudna active positions
| Companies | Position | Start |
|---|---|---|
| JOHNSON & JOHNSON | Director/Board Member | 2018-02-12 |
| TEMPUS AI, INC. | Director/Board Member | 2021-03-31 |
| EFFECTOR THERAPEUTICS, INC. | Consultant / Advisor | - |
Driver, Inc.
 Driver, Inc. Packaged SoftwareTechnology Services Develops software platform that connects cancer patients to treatments | Director/Board Member | - |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Private Equity Investor | - |
Li Ka Shing (Canada) Foundation | Corporate Officer/Principal | - |
Innovative Genomics Institute
 Innovative Genomics Institute BiotechnologyHealth Technology Operates as a scientific research institution that develops genome engineering tools to treat human diseases | Founder | 2013-12-31 |
Altos Labs, Inc.
 Altos Labs, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on restoring cell health and rejuvenation resilience | Director/Board Member | - |
TPG Sixth Street Partners LLC
 TPG Sixth Street Partners LLC Investment ManagersFinance Sixth Street TAO invests in middle-market and large-cap public and private companies located across the globe. The firm targets companies operating across a broad range of sectors and industries. It provides financing for later stage, growth, buyout, infrastructure, special situations and recapitalization in the form of equity and debt with an investment size of USD 50 million - 2.5 billion. The firm also acquires minority and majority interests. It also makes follow-on investments. | Consultant / Advisor | 2022-02-07 |
| ░░░░░░░░ ░░░░░░░ ░░ ░░░░ ░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Former positions of Jennifer Doudna
| Companies | Position | End |
|---|---|---|
| ░░░ ░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ ░░░░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░ | - |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Jennifer Doudna
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
90
1st degree connections
26
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 26 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Caribou Biosciences, Inc.
 Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
Pomona College
 Pomona College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal Society
 The Royal Society Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Howard Hughes Medical Institute, Inc.
 Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lawrence Berkeley National Laboratory
 Lawrence Berkeley National Laboratory Miscellaneous Commercial ServicesCommercial Services Researches on environmental studies, nanoscience and quantitative biology, physics and nuclear energy | Commercial Services |
Orchard Venture Partners
 Orchard Venture Partners Investment ManagersFinance Orchard Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of technology and medical sectors. It provides financing for early and later-stage capital requirements. | Finance |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Commercial Services |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Commercial Services |
Li Ka Shing (Canada) Foundation | |
The Column Group LLC
The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Finance |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Ltd. | |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Tempus AI, Inc.
 Tempus AI, Inc. Packaged SoftwareTechnology Services Develops clinical & molecular data platform for healthcare | Technology Services |
TPG Sixth Street Partners LLC
TPG Sixth Street Partners LLC Investment ManagersFinance Sixth Street TAO invests in middle-market and large-cap public and private companies located across the globe. The firm targets companies operating across a broad range of sectors and industries. It provides financing for later stage, growth, buyout, infrastructure, special situations and recapitalization in the form of equity and debt with an investment size of USD 50 million - 2.5 billion. The firm also acquires minority and majority interests. It also makes follow-on investments. | Finance |
Driver, Inc.
Driver, Inc. Packaged SoftwareTechnology Services Develops software platform that connects cancer patients to treatments | Technology Services |
Mammoth Biosciences, Inc.
 Mammoth Biosciences, Inc. Internet Software/ServicesTechnology Services Operates CRISPR-based platform for disease detection | Technology Services |
Scribe Therapeutics, Inc.
 Scribe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops CRISPR-based genetic medicines | Health Technology |
eFFECTOR Therapeutics, Inc.
 eFFECTOR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a oncology company which develops therapies for cancer | Health Technology |
Altos Labs, Inc.
Altos Labs, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on restoring cell health and rejuvenation resilience | Health Technology |
Innovative Genomics Institute
Innovative Genomics Institute BiotechnologyHealth Technology Operates as a scientific research institution that develops genome engineering tools to treat human diseases | Health Technology |
- Stock Market
- Insiders
- Jennifer Doudna
